Aktie A40161 PROCESSA PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Processa Pharmaceuticals, Inc.

Aktien

A40161

US74275C3043

PCSA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 26.04.2024 		% 5 Tage % 1. Jan.
2.15 USD -11.52% Intraday Chart für Processa Pharmaceuticals, Inc. +36.08% -67.87%
26.04. Die größten Verlierer der Vorbörse MT
25.04. Top-Zuwächse am Mittag MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Top Premarket Decliners
Top Midday Gainers
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Processa Pharmaceuticals, Inc. Presents Two Abstracts At the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1B Trial
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
Sector Update: Health Care Stocks Stronger Late Afternoon
Top Midday Decliners
Sector Update: Health Care Stocks Higher Friday Afternoon
Processa Pharmaceuticals Prices $7 Million Common Stock Offering
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Sector Update: Health Care Stocks Softer Late Afternoon
Top Midday Gainers
Processa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatment
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A40161 Aktie
  4. Nachrichten Processa Pharmaceuticals, Inc.
  5. Andere Sprachen